Clinical Trials List
Protocol NumberCJSB462C12201
Active
2025-07-01 - 2029-02-12
Phase II
Recruiting2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- 謝宜珈 無
- Kwang-Yu Chang Division of Hematology & Oncology
- 林琨哲 無
- Che-Yuan Hu 無
- Kuan-Yu Wu 無
- Wen-Pin Su 無
- 姜伯璋 無
- 詹皓程 無
- 鍾秉軒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
150 participants
